Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Personalized Medicine And Palmetto’s MolDx: Raising The Bar On Evidence

This article was originally published in The Gray Sheet

Executive Summary

Diagnostic industry players support the regional Medicare contractor’s evidence-based reimbursement requirements for molecular diagnostics and are hoping CMS adopts the approach nationally.

Advertisement

Related Content

Promise Of MolDx Program For Molecular Tests Unfulfilled, Labs Say
Ex-CMS Louis Jacques On Partnering With FDA And Keeping It Local
BRCA Reimbursement Cut Heightens Tensions Between CMS And Lab Industry
Qiagen Sees Brighter Reimbursement Outlook For Companion Diagnostics
Qiagen Sees Brighter Reimbursement Outlook For Companion Diagnostics
Reimbursement Briefs: National Coverage Updates; MolDx Meeting Request; Sleep Study Questions
MolDx Labs Question Missing Medicare Payment Amounts For Some Test Codes
MolDx Labs Question Missing Medicare Payment Amounts For Some Test Codes
Reimbursement Briefs: OIG Looks At DME; AHRQ Seeks Imaging Info; MolDx News
Molecular Dx Reimbursement: Medicare Contractor Seeks Tighter Controls

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT031790

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel